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Abstract: Mangosteen, Garcinia mangostana Linn, is a tree found in South East Asia, and 
its pericarps have been used as traditional medicine. Phytochemical studies have shown that 
they contain a variety of secondary metabolites, such as oxygenated and prenylated 
xanthones. Recent studies revealed that these xanthones exhibited a variety of biological 
activities containing anti-inflammatory, anti-bacterial, and anti-cancer effects. We 
previously investigated the anti-proliferative effects of four prenylated xanthones from the 
pericarps;  α-mangostin,  β-mangostin,  γ-mangostin, and methoxy-β-mangostin in various 
human cancer cells. These xanthones are different in the number of hydroxyl and methoxy 
groups. Except for methoxy-β-mangostin, the other three xanthones strongly inhibited cell 
growth at low concentrations from 5 to 20 μM in human colon cancer DLD-1 cells. Our 
recent study focused on the mechanism of α-mangostin-induced growth inhibition in DLD-1 
cells. It was shown that the anti-proliferative effects of the xanthones were associated with 
cell-cycle arrest by affecting the expression of cyclins, cdc2, and p27; G1 arrest by α-
mangostin and β-mangostin, and S arrest by γ-mangostin. α-Mangostin found to induce 
apoptosis through the activation of intrinsic pathway following the down-regulation of 
signaling cascades involving MAP kinases and the serine/threonine kinase Akt. Synergistic 
effects by the combined treatment of α-mangostin and anti-cancer drug 5-FU was to be 
noted.  α-Mangostin was found to have a cancer preventive effect in rat carcinogenesis 
bioassay and the extract from pericarps, which contains mainly α-mangostin and γ-
mangostin, exhibited an enhancement of NK cell activity in a mouse model. These findings 
could provide a relevant basis for the development of xanthones as an agent for cancer 
prevention and the combination therapy with anti-cancer drugs.  
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1. Overview 
The mangosteen tree has been cultivated for centuries in tropical areas of the world. The tree is 
presumed to have originated in Southeast Asia or Indonesia and has largely remained indigenous to 
Malay Peninsula, Myanmar, Thailand, Cambodia, Vietnam and the Moluccas (Figure 1A). The white, 
inner pulp of the mangosteen fruit is highly praised as one of the best tasting of all tropical fruits. The 
scientific name is Garcinia mangostana. The entire fruit is typically 2.5-7.5 cm in diameter, roughly 
the size of a tangerine (Figure 1B). The rind (or skin) of the fruit is 0.6-1.0 cm thick and contains a 
purplish pigment. The inner pulp consists of four to eight juicy, white-colored segments (fruit portion, 
Figure 1B). The edible portion of the fruit comprises only about 25% of the total volume, whereas the 
remainder is tough, bitter pericarp which exudes a yellow resin (hence the term xanthones or yellow in 
Greek)(Figure 1B). The mangosteen rind, leaves and bark have been used as folk medicine for 
thousands of years. The thick mangosteen rind has been and is used for treating catarrh, cystitis, 
diarrhea, dysentery, eczema, fever, intestinal ailments, pruritis and other skin ailments. The 
mangosteen leaves are also used by some natives in teas and for diarrhea, dysentery, fever, and thrush. 
It is also known that concentrates of mangosteen bark can be used for genito-urinary afflictions and 
stomatosis. 
Figure 1. The Garcinia mangostana Linn tree (A), the appearance of mangosteen fruit (B) 
and the chemical structures of xanthones included in the pericarps (C). 
 
2. Introduction 
Increasing attention has been paid to primitive medicinal plants and dietary factors to search for 
new substances with potentially effective anti-cancer activity. A large number of natural products have 
been evaluated as potential chemopreventive or therapeutic agents. In fact, among these compounds, 
paclitaxel, etoposide, camptothecin, and vincristine, have been used as anticancer drugs. 
Epidemiological studies have shown that dietary phytochemicals provide beneficial effects on cancer Int. J. Mol. Sci. 2008, 9  357
 
 
prevention [1-4]. In this context, evidence-based biofactors for cancer prevention are strongly required 
for practical use. Among them, polyphenols are of great interest as chemopreventive agents because of 
their anti-oxidative and possible anti-cancer activity [1-6].  
      In our series of investigations to search for anti-cancer agents from plant sources, all the 
polyphenols and terpenoids tested which exhibited an anti-proliferative effect, were observed to induce 
apoptosis by targeting mitochondria with a decreased membrane potential, leading to the activation of 
the intrinsic apoptotic signal transduction [7-13]. In some cases, the early responsive signaling 
cascades including protein kinases MAPK and Akt referring to growth and survival, respectively, were 
down-regulated [13]. 
   Our previous reports indicated a potent anti-proliferative activity of 4 xanthones (α-mangostin, β-
mangostin, γ-mangostin, and methoxy- β-mangostin) from the pericarps of mangosteen against human 
leukemia HL60 cells. Interestingly, α-mangostin was observed to induce mitochondrial  dysfunction 
[11]. Moreover, it induced cell-cycle arrest and apoptosis in human colon cancer DLD-1 cells [14]. In 
this review, we discuss the mechanism of anti-cancer effect of xanthones and the possibility of 
chemopreventive agents for cancer, especially in α-mangostin and γ-mangostin. 
3. Chemistry of Xanthones 
   The subsurface chemistry of the mangosteen pericarp comprises an array of polyphenolic acids 
including xanthones and tannins that assure astringency to discourage infestation by insects, fungi, 
plant viruses, bacteria and animal predation while the fruit is immature. Color changes and softening 
of the pericarp are natural processes of ripening, which indicates that the fruit can be eaten and the 
seeds finish developing. Among the constituents of the pericarps, xanthones are biologically active 
phenols that naturally occur in a restricted group of plants [15-17]. Over 200 xanthones are currently 
known to exist in nature and approximately 50 of them are found in the mangosteen. The xanthones 
possess a six-carbon conjugated ring structure with multiple double carbon bonds. The chemical 
structures of 4 major xanthones contained in percarps are shown in Figure 1C. The prenyl group is 
considered to be implicated in the internalization into the cell, which in turn leads to interaction with 
the signal transduction molecules and the proteins involved in mitochondria permeability transition 
[18,19]. 
4. Growth Inhibitory Effect of Prenylated Xanthones 
   The major 4 structurally similar prenylated xanthones [α-mangostin (αΜ), β-mangostin (βΜ), γ-
mangostin (γΜ), and methoxy-β-mangostin (βΜ−ΜE)] from the pericarps of mangosteen were 
examined for the effect on the growth of human colon cancer DLD-1 cells (Figure 2). Except for 
methoxy-β-mangostin, other xanthones displayed growth inhibitory effects. From the values of the 
IC50, the inhibitory activity was estimated; βΜ-ΜE<βΜ<αΜ<γΜ (Table 1). The Hoechst 33342 
staining and DNA electrophoretic analysis demonstrated that the anti-proliferative effect of α-
mangostin, which is the major constituent of the extract, is due to the apoptotic process (Figure 3). 
   In comparison with the anti-cancer drugs such as 5-FU, actinomycin D and camptothecin used for 
the patients with colon cancer, the IC50 of α-mangostin was close to that of 5-FU (Table 1). However, Int. J. Mol. Sci. 2008, 9  358
 
 
the morphological changes by α-mangostin was quite distinct from those induced by 5-FU   
(Figure 3A).  
Figure 2. Effect of xanthones on cell growth in human colon cancer DLD-1 cells.  
 
Table 1. Growth inhibitory effect (IC50) of α-mangostin and anti-cancer drugs in 
DLD-1 cells. 
 
5. Mechanism of α-Mangostin-inducing Apoptosis 
   In our previous study, it was demonstrated that α-mangostin activated caspase-9 and -3 but not -8 
in HL60 cells, indicating that α-mangostin may mediate the mitochondrial pathway in the apoptotic Int. J. Mol. Sci. 2008, 9  359
 
 
process [11]. Parameters of mitochondrial dysfunctions such as swelling, loss of membrane potential, 
decrease in intracellular ATP, ROS accumulation, and cytochrome c/AIF release, were observed 
within 1 or 2 h after the treatment, indicating that α-mangostin preferentially targets mitochondria in 
the early phase [11]. Interestingly, replacement of hydroxyl group by methoxy group (Figure 1C) 
remarkably decreased the potency to cause mitochondrial dysfunction. It was also shown that the 
cytotoxicity was correlated with the decrease in the mitochondrial membrane potential. Furthermore, 
we demonstrated that
 α-mangostin induced a cell cycle arrest at G1/S and the subsequent apoptosis via 
the intrinsic pathway in DLD-1 cells, while a cell cycle arrest by γ-mangostin was at S phase (Figure 
4A and B) [14]. The changes in expression of cell cycle regulatory proteins were shown in Figure 4C. 
α-Mangostin-induced apoptosis was mediated by a caspase-independent pathway via mitochondria 
with the release of Endo-G (Figure 5) [13]. Endo-G, a known 30-kD nuclease residing in 
mitochondria, is able to induce nucleosomal DNA fragmentation [13]. 
Figure 3. The cell death induced by α-mangostin and 5-FU. Hoechst 33342 staining (A) 
and nucleosomal DNA fragmentation (B). 
 
   Many  serine/threonine  protein  kinases  control cell growth, proliferation, differentiation, cell 
cycle, survival and death. Mitogen-activated protein kinases (MAPKs) and Akt kinase are key 
regulatory proteins in cells. MAPKs are a widely conserved family of serine/threonine protein kinases 
involved in many cellular processes such as cell proliferation, differentiation, motility, and death [20]. 
Akt, another serine/threonine protein kinase, is associated with cell survival, growth, and glycogen 
metabolism [21]. Various phytochemicals, including epigallocatechin-3-gallate [22], resveratrol [23],
 
arucanolide
 [10] etc., have been shown to modulate the signaling pathways of MAPKs and/or Akt, 
leading to growth inhibition and cell death.  Int. J. Mol. Sci. 2008, 9  360
 
 
      The levels of phosphorylation of p38 and p-JNK appeared to change within 24 h after the 
treatment with α-mangostin, but their changes could not be properly explained (Figure 6). The levels 
of p-Erk1/2 showed 2 peaks at the early and late phases. Recently, the dual expression of p-Erk1/2 was 
also 2 peaks observed in HT-22 cells exposed to glutamate-induced oxidative stress [24]. Erk1/2 may 
play a dual role, acting first as a cellular adaptive response at the initial phase and then as a cytotoxic 
response at the later stage. As reported [24],
 the decline in p-Erk1/2 after the later peak may be 
associated with the apoptotic machinery. On the other hand, in the Akt signaling the level of p-Akt was 
markedly reduced at 6 h following α-mangostin treatment (Figure 6), coincident with the occurrence 
of apoptosis. Therefore, down-regulation of Akt signaling could participate in the mechanism of 
apoptosis induced by α-mangostin.  
 
Figure 4. Effect of xanthones on cell cycle progression.  
 
 
   Intriguingly, we have recently found that α-mangostin up-regulated the expression of miRNA-143 
(Figure 7)[13]. miR-143 is highly expressed especially in normal colon tissues, but its expression in 
human colon cancer tumors is markedly decreased [25,26]. We determined its target mRNA to be 
ERK5 by introducing miRNA-143 into DLD-1 cells [25,26]. α-Mangostin increased the expression 
levels of miRNA-143 in the process of the apoptotic cell death probably by modulating its 
transcription and/or the upstream signals associated with the transcription factors of miR-143 [13]. The 
molecular mechanism of the apoptotic cell death induced by α-mangostin in DLD-1 cells is 
schematically summarized in Figure 8. α-Mangostin first affects the cell cycle i.e. arrest at G1/S and Int. J. Mol. Sci. 2008, 9  361
 
 
thereafter induces apoptosis which is mediated by the intrinsic pathway through mitochondria, which 
follows the modulation of the growth-related signal transduction via MAPK Erk1/2 and Akt, and the 
expression level of miRNA-143, a target of ERK5. 
Figure 4. (continued) 
 
6. Combined Treatment of α-Mangostin with Anticancer Drugs 
   In view of recent phytochemical studies, it has been pointed out that such substances included in 
vegetables and fruits could affect the efficacy of anti-cancer drugs and their metabolism [27], because 
many of the patients with cancer take folk medicines and supplements in addition to anti-cancer drugs. 
Therefore, it is important to study the interaction between phytochemicals and anti-cancer drugs. 
Furthermore, strategies aimed at enhancing the therapeutic efficiency of anti-cancer drugs and 
decreasing the side effect involve its administration schedule and also its use in combination with 
phytochemicals for a better treatment response [27,28]. 5-FU, which is one of the most effective 
chemotherapeutic agents for colorectal adenocarcinoma [28],
 can produce response rates of ~11% 
when used as a single agent [28]. For example, folinic acid [28], leucovorin (LV) [29-31], oxaliplatin 
(L-OHP), LV in the FOLFOX regimen [32], and irinotecan (CPT-11) and LV in the FOLFIRI regimen 
[33] are combination therapies for colorectal cancer patients.  Int. J. Mol. Sci. 2008, 9  362
 
 
Figure 5. α-Mangostin-induced apoptosis in DLD-1 cells.  
 
 
Figure 6. Activities of MAP kinases and Akt kinase in 20 µM α-mangostin-treated DLD-1 cells. 
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Figure 7. Semi-qRT-PCR-evaluated or TaqMan
® probe assay (Real-Time PCR)-evaluated  
miRNA-143.  
 
 
Figure 8. A scheme showing the possible mechanisms of α-mangostin-induced cell death. 
 
 
   We demonstrated the synergistic effect on cell growth when 5-FU was used with α-mangostin 
(total 2 and 5 µM) (Figure 9A). The growth inhibition by 5-FU was probably due to cell cycle arrest at Int. J. Mol. Sci. 2008, 9  364
 
 
the concentrations tested [34], because no apoptotic cells were observed (Figure 3A). At more than 15 
µM α-mangostin, apoptotic cells were observed, whereas at lower concentrations α-mangostin most 
likely causes cell cycle arrest like 5-FU. Therefore, the synergistic effect by the combined treatment at 
the total 2 and 5 µM concentrations was probably due to the additional enhancement of the machinery 
leading to cell cycle arrest. Indeed, the expression of cell cycle-related proteins such as cyclin D1 and 
c-Myc at total 5 µM was significantly reduced at 24 h, compared with that found in single each agent 
(Figure 9B).    
It is possible that the mechanism of growth suppression by α-mangostin is different from that of 5-
FU at more than 15 µM, because the growth inhibition obtained by a single treatment with α-
mangostin was greater compared with that by the combined treatment. It is possible that the more 
potent apoptosis-inducing activity of α-mangostin which was observed at more than 15 µM, was not 
induced by the combination with 5-FU at both 7.5 µM and 10 µM. In this context, the activation of 
MAPKs and Akt signal pathways, which were changed by the treatment with 20 µM α-mangostin 
alone, could be reduced in the single treatment of α-mangostin or 5-FU. Thus, phytochemicals are 
conceivable to exert a considerable effect on the efficacy of anti-cancer agents, depending on their 
concentrations, by modulating the intracellular signaling pathways [27].
 The enhanced efficacy of α-
mangostin with other anti-cancer agents was also shown by our recent study.   
Figure 9. Synergistic growth-inhibiting effect in the combined treatment with α-mangostin 
and 5-FU in DLD-1 cells.  
7. Cancer Preventive Effect in vivo 
   We  examined  whether  α-mangostin has short-term chemopreventive effects on putative 
preneoplastic lesions involved in rat colon carcinogenesis [35]. Rats in groups 1-3 were given a 
subcutaneous injection of carcinogen 1,2-dimethylhydrazine (DMH)(40 mg/kg body weight) once a 
week for 2 weeks. Dietary administration of α-mangostin at doses of 0.02% and 0.05% α-mangostin 
significantly inhibited the induction and/or development of aberrant crypt foci (ACF) (P<0.05 for 
0.02%  α-mangostin, P<0.01 for 0.05% α-mangostin), when compared to the DMH-treated group Int. J. Mol. Sci. 2008, 9  365
 
 
(group 1)(Figure 10). Moreover, treatment of rats with 0.05% α-mangostin significantly decreased 
dysplastic foci and β-catenin accumulated crypts, to below the group 1 values [35]. The finding that α-
mangostin has potent chemopreventive effects in our short-term colon carcinogenesis bioassay system 
suggests that the longer exposure would result in suppression of tumor development. 
Figure 10. Body weight, liver weight, and the number of atypical crypt foci in the colon 
from BALB/C control mice and mice treated with 0.02% and 0.05 % dietary α-mangostin. 
 
8. Immunomodulatory Effect 
      Natural killer (NK) cell works as the main immune cells of the innate immunity, and it is 
especially important in the eradication of the tumor cells and the virus infected cells. However, the 
activity of the NK cell decreases with aging after the peak at about 15 years old. The morbidity rate of 
people with cancer is rising by aging, which may be related to the decline of the activity of the NK cell 
activity.  
   We  investigated  the  effect  of  α-mangostin on NK cell activity using a mouse model. We 
administrated the α-mangostin-enriched extract from pericarps named Panaxanthone (α-mangostin, 
80-90%; γ-mangostin, 5-10%) to mice everyday by gavage with different doses for 30 days. The NK 
cell activity was determined by measuring LDH after the incubating of YAC-1 cells (target cells) and 
splenocytes (effector cells) at the ratio of 1:50. The activities of 20 and 40 mg/kg groups were 
significantly elevated compared with that in control group 0 mg/kg (Figure 11). A significant increase Int. J. Mol. Sci. 2008, 9  366
 
 
in the NK cell activity by Panaxanthone was also observed in the human pilot study using healthy 
people at the dose of 150 mg/day per a person for 7 days.  
Figure 11. Effect of mangosteen pericarps extract Panaxanthone on the activity of NK 
cells in mice.  
 
9. Conclusion and Future Perspectives 
   The anti-proliferative activity of α-mangostin is markedly high, because the IC50 of α-mangostin 
is almost same as that of 5-FU in DLD-1 cells. Its activity is mainly due to apoptosis. The apoptotic 
observations such as morphological changes and DNA ladder formation emerged at 24 h-treatment 
with α-mangostin, while the decrease in the mitochondrial membrane potential and the release of 
Endo-G observed at 6 h-treatment. These events were preceded by the inactivation of the signaling 
cascades involving Erk1/2 and Akt at 3 h-treatment. The cell cycle regulatory proteins cyclin D1 and 
cdc2 were also down-regulated at 3 h-treatment. Since the swelling of mitochondria was observed at 1 
h-treatment,  α-mangostin most likely attacks the proteins involved in permeability transition of 
mitochondria. This event could trigger the cell cycle arrest and apoptosis (Figure 8). 
   Considering  the  chemopreventive  effects  of phytochemicals, they may depend on three main 
activities: anti-oxidant, apoptosis inducing, and phase II enzymes inducing. In our studies, we have 
verified such activities in α-mangostin. It has been already known that the ORAC (Oxygen Radical 
Absorbance Capacity) value of mangosteen is makedly high [36](www,naturalproductsassoc.org). α-
Mangostin increased the expression of glutathione S-transferase (GST) at 0.5-5.0 µM for 12 h-
treatment in human hepatocellular carcinoma HuH-7 cells. Furthermore, recent study has revealed that 
the suppression of inflammatory reaction by phytochemicals leads to cancer prevention. The 
xanthones, which have anti-oxidant activity, have been reported to reduce the expression of 
cyclooxygenase-2 (COX-2) [37-39] and to suppress the nuclear factor-κB (NF-κB)[37,40]. 
      Recently, we succeeded in crystallizing the extract from the pericarps and found that the 
substance contains more than 90% xanthones (α-mangostin, 80-90%; γ-mangostin, 5-10%). This was 
named Panaxanthone, and assessed to be safe by a conventional safety test using mouse model. The Int. J. Mol. Sci. 2008, 9  367
 
 
safety was further confirmed by the fact that these xanthones have been used as a folk medicine for 
many years and more than 160 kinds of fruits juice containing whole extract of mangosteen are 
distributed worldwide. The safety clinical trial of Panaxanthone is under progress, leading to 
development for a cancer preventive and therapeutic agent.    
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